Javascript must be enabled to continue!
DIAGNOSTIC ACCURACY OF STOOL XPERT MTB/ RIF FOR THE DIAGNOSIS OF PULMONARY TUBERCULOSIS IN CHILDREN'S LESS THAN 15 YEARS OF AGE KEEPING GASTRIC ASPIRATE/SPUTUM XPERT MTB/RIF AS GOLD STANDARD
View through CrossRef
Background: Childhood tuberculosis (TB) is poorly diagnosed because of the challenges in getting sputum samples and the paucibacillary nature of the disease. Xpert MTB/RIF based on stool has developed as an alternative non-invasive method of diagnosis. Objective: To determine diagnostic accuracy of stool xpert MTB/ RIF for the diagnosis of tuberculosis in children's less than 15 years of age keeping gastric Aspirate/Sputum Xpert MTB/RIF as reference standard. Methodology: This is a cross-sectional study, which was done in the Department of Pediatric Medicine, Children Hospital Lahore from November 2025 to February 2026. The sample size was 185 children (<15 years) suspected of pulmonary TB who were recruited using non-probability consecutive sampling. Samples of stool and respiratory were collected and tested with Xpert MTB/RIF assay. The measures of diagnostic accuracy such as sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy were determined using a 2x2 contingency table. Result: The average age of the sample was 7.2 +/- 3.8 years and 56.2 percent of the sample was males. The prevalence of TB was 23.2% according to the reference standard. Stool Xpert MTB/RIF showed a sensitivity of 90.7, specificity of 94.4, PPV of 85.9 and NPV of 96.8. The total diagnostic accuracy was 93.0%. Conclusion: Stool Xpert MTB/RIF is a non-invasive, high sensitivity and specificity diagnostic tool to identify pulmonary TB in children. It may be of special benefit in a resource-constrained environment in which sputum samples are difficult to obtain.
Title: DIAGNOSTIC ACCURACY OF STOOL XPERT MTB/ RIF FOR THE DIAGNOSIS OF PULMONARY TUBERCULOSIS IN CHILDREN'S LESS THAN 15 YEARS OF AGE KEEPING GASTRIC ASPIRATE/SPUTUM XPERT MTB/RIF AS GOLD STANDARD
Description:
Background: Childhood tuberculosis (TB) is poorly diagnosed because of the challenges in getting sputum samples and the paucibacillary nature of the disease.
Xpert MTB/RIF based on stool has developed as an alternative non-invasive method of diagnosis.
Objective: To determine diagnostic accuracy of stool xpert MTB/ RIF for the diagnosis of tuberculosis in children's less than 15 years of age keeping gastric Aspirate/Sputum Xpert MTB/RIF as reference standard.
Methodology: This is a cross-sectional study, which was done in the Department of Pediatric Medicine, Children Hospital Lahore from November 2025 to February 2026.
The sample size was 185 children (<15 years) suspected of pulmonary TB who were recruited using non-probability consecutive sampling.
Samples of stool and respiratory were collected and tested with Xpert MTB/RIF assay.
The measures of diagnostic accuracy such as sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy were determined using a 2x2 contingency table.
Result: The average age of the sample was 7.
2 +/- 3.
8 years and 56.
2 percent of the sample was males.
The prevalence of TB was 23.
2% according to the reference standard.
Stool Xpert MTB/RIF showed a sensitivity of 90.
7, specificity of 94.
4, PPV of 85.
9 and NPV of 96.
8.
The total diagnostic accuracy was 93.
0%.
Conclusion: Stool Xpert MTB/RIF is a non-invasive, high sensitivity and specificity diagnostic tool to identify pulmonary TB in children.
It may be of special benefit in a resource-constrained environment in which sputum samples are difficult to obtain.
Related Results
Evaluasi sensitivitas dan spesifisitas Xpert MTB RIF dan Xpert MTB RIF Ultra pada berbagai spesimen untuk mendiagnosis tuberkulosis ekstra paru: Sebuah telaah literatur sistematis
Evaluasi sensitivitas dan spesifisitas Xpert MTB RIF dan Xpert MTB RIF Ultra pada berbagai spesimen untuk mendiagnosis tuberkulosis ekstra paru: Sebuah telaah literatur sistematis
Background: Molecular examination using Xpert MTB RIF and Xpert MTB RIF Ultra was introduced by WHO in 2010 as a fast and practical supporting examination in detecting Mycobacteriu...
Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
Abstract
Background
Uganda introduced Xpert® MTB/RIF assay into its TB diagnostic algorithm in January 2012. In July 2018, this...
Comparison evaluation between gene Xpert Mtb/Rif and multiplex PCR for rapid diagnosis of mycobacterium tuberculosis
Comparison evaluation between gene Xpert Mtb/Rif and multiplex PCR for rapid diagnosis of mycobacterium tuberculosis
Abstract
Objective: To evaluate Gene Xpert MTB/RIF and Multiplex PCRfor detection of Mycobacterium tuberculosis and Rifampicin resistance comparing with gold standard MGIT 96...
Stool-based Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children at a teaching and referral hospital in Southwest Ethiopia
Stool-based Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children at a teaching and referral hospital in Southwest Ethiopia
Background
Diagnosis of tuberculosis (TB) in children is challenging mainly due to the difficulty of obtaining respiratory specimen and lack of sensitive diagnostic tests. The obje...
The Value of Lateral Flow Urine Lipoarabinomannan Assay and Empirical Treatment in the Xpert MTB/RIF Ultra Era: a Prospective Cohort Study
The Value of Lateral Flow Urine Lipoarabinomannan Assay and Empirical Treatment in the Xpert MTB/RIF Ultra Era: a Prospective Cohort Study
Abstract
Introduction: The value of Lateral Flow urine Lipoarabinomannan (LF-LAM) assay and the role of empiric tuberculosis (TB) treatment in the era of the highly sensiti...
Diagnostic accuracy of swab-based molecular tests for tuberculosis using novel near point-of-care platforms: A multi-country evaluation
Diagnostic accuracy of swab-based molecular tests for tuberculosis using novel near point-of-care platforms: A multi-country evaluation
SummaryBackgroundSwab-based molecular platforms that enable testing of both sputum (via swabs swirled in sputum) and tongue swabs are emerging as a promising option for more access...
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
Abstract
Background
The main advantage of GeneXpert MTB/RIF® (Xpert) molecular diagnostic technology is the rapid detection of M.tuberculosis DNA and mutations associated with rifa...
Effect of sputum quality and role of Xpert® MTB/RIF assay for detection of smear-negative pulmonary tuberculosis in same-day diagnosis strategy in Addis Ababa, Ethiopia
Effect of sputum quality and role of Xpert® MTB/RIF assay for detection of smear-negative pulmonary tuberculosis in same-day diagnosis strategy in Addis Ababa, Ethiopia
Background: There is limited information on the performance of the Xpert® MTB/RIF test for diagnosis of smear-negative pulmonary tuberculosis (SNPT) and rifampicin resistance (RR) ...

